Treatment of Group I Pulmonary Arterial Hypertension with Carvedilol Is Safe-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of Group I Pulmonary Arterial Hypertension with Carvedilol Is Safe

Published:2014-06-15 Issue:12 Volume:189 Page:1562-1564
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Grinnan Daniel,Bogaard Harm-Jan,Grizzard John,Van Tassell Benjamin,Abbate Antonio,DeWilde Christine,Priday Anna,Voelkel Norbert F.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference14 articles.

1. Pulmonary arterial hypertension

2. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: Insights from the REVEAL Registry

3. The Right Ventricle Under Pressure

4. Mechanisms of Right Heart Failure—A Work in Progress and a Plea for Failure Prevention

5. Usefulness of Beta-Blocker Therapy and Outcomes in Patients With Pulmonary Arterial Hypertension

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Eisenmenger syndrome – Review of pathophysiology and recent progress in risk assessment and management;International Journal of Cardiology Congenital Heart Disease;2024-09

2. The Right Ventricle in Pulmonary Arterial Hypertension: An Organ at the “Heart of the Problem”;Current Respiratory Medicine Reviews;2024-08

3. Atrial Arrhythmias in Patients With Pulmonary Hypertension;CHEST;2024-07

4. The selective serotonin reuptake inhibitor paroxetine improves right ventricular systolic function in experimental pulmonary hypertension;Journal of Molecular and Cellular Cardiology Plus;2024-06

5. Beta-adrenergic blockade increases pulmonary vascular resistance and causes exaggerated hypoxic pulmonary vasoconstriction at high altitude: a physiological study;European Heart Journal - Cardiovascular Pharmacotherapy;2024-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3